Optimising the duration of adjuvant trastuzumab in early breast cancer in the UK

Helena M Earl; Louise Hiller; Janet Dunn; Iain Macpherson; Daniel Rea; Luke Hughes-Davies; Karen McAdam; Peter S Hall; Janine Mansi; Duncan Wheatley; Jean Abraham; Carlos Caldas; Sophie Gasson; Liz O'Riordan; Maggie Wilcox; David  Miles; David A Cameron; Andrew Wardley

doi:10.1016/j.clon.2020.07.006

Optimising the duration of adjuvant trastuzumab in early breast cancer in the UK

Helena M Earl, Louise Hiller, Janet Dunn, Iain Macpherson, Daniel Rea, Luke Hughes-Davies, Karen McAdam, Peter S Hall, Janine Mansi, Duncan Wheatley, Jean Abraham, Carlos Caldas, Sophie Gasson, Liz O'Riordan, Maggie Wilcox, David Miles, David A Cameron, Andrew Wardley

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Clinical Oncology
DOIs	https://doi.org/10.1016/j.clon.2020.07.006
Publication status	Published - 25 Jul 2020

Access to Document

10.1016/j.clon.2020.07.006

Clean Optimising the duration of adjuvant trastuzumab in early breast cancer in the UK 03June2020 v final revision
This is a pre-copyedited, author-produced version of an article accepted for publication in Clinical Oncology following peer review. The version of record " Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK" is available online at: https://doi.org/10.1016/j.clon.2020.07.006
Accepted author manuscript, 354 KB

Cite this

M Earl, H., Hiller, L., Dunn, J., Macpherson, I., Rea, D., Hughes-Davies, L., McAdam, K., Hall, P. S., Mansi, J., Wheatley, D., Abraham, J., Caldas, C., Gasson, S., O'Riordan, L., Wilcox, M., Miles, D., Cameron, D. A., & Wardley, A. (2020). Optimising the duration of adjuvant trastuzumab in early breast cancer in the UK. Clinical Oncology. https://doi.org/10.1016/j.clon.2020.07.006

@article{4d80d3fa2eb443e5867b9431fd468341,

title = "Optimising the duration of adjuvant trastuzumab in early breast cancer in the UK",

author = "{M Earl}, Helena and Louise Hiller and Janet Dunn and Iain Macpherson and Daniel Rea and Luke Hughes-Davies and Karen McAdam and Hall, {Peter S} and Janine Mansi and Duncan Wheatley and Jean Abraham and Carlos Caldas and Sophie Gasson and Liz O'Riordan and Maggie Wilcox and David Miles and Cameron, {David A} and Andrew Wardley",

year = "2020",

month = jul,

day = "25",

doi = "10.1016/j.clon.2020.07.006",

language = "English",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "Elsevier Science",

}

TY - JOUR

T1 - Optimising the duration of adjuvant trastuzumab in early breast cancer in the UK

AU - M Earl, Helena

AU - Hiller, Louise

AU - Dunn, Janet

AU - Macpherson, Iain

AU - Rea, Daniel

AU - Hughes-Davies, Luke

AU - McAdam, Karen

AU - Hall, Peter S

AU - Mansi, Janine

AU - Wheatley, Duncan

AU - Abraham, Jean

AU - Caldas, Carlos

AU - Gasson, Sophie

AU - O'Riordan, Liz

AU - Wilcox, Maggie

AU - Miles, David

AU - Cameron, David A

AU - Wardley, Andrew

PY - 2020/7/25

Y1 - 2020/7/25

U2 - 10.1016/j.clon.2020.07.006

DO - 10.1016/j.clon.2020.07.006

M3 - Article

SN - 0936-6555

JO - Clinical Oncology

JF - Clinical Oncology

ER -